Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study.
María Dolores Martín ArranzLaura García-RamírezEduardo Martín ArranzDolores Montero VegaJosé Luis Rueda GarcíaMaría Sánchez-AzofraJoaquín Poza CordónJesús Noci BeldaTamara Verges Martínez-MecoPaula Blanco San MiguelCristina Suárez FerrerPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2023)
the antibody response after vaccination against SARS-CoV-2 is high in patients with inflammatory bowel disease. However, patients treated with immunosuppressive or biologic drugs had a lower response. Adverse events were frequent, but not serious.